Product Images Aripiprazole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Aripiprazole NDC 50090-6403 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure - aripiprazole fig1

figure - aripiprazole fig1

The text describes the effect of different drugs on Aripiprazole, indicating the fold change and 90% confidence interval. Several inhibitors and inducers of enzymes such as CYP3AA and CYP206 are mentioned, along with others like valproate and lorazepam. The text also mentions the change relative to the reference without the interacting drug.*

figure - aripiprazole fig2

figure - aripiprazole fig2

This appears to be a chart or table showing the effect of various drugs on aripiprazole metabolism, including inhibitors and inducers of specific enzymes and other interacting drugs. It also includes data measurements like AuC, Cmax, and fold change with corresponding confidence intervals.*

figure - aripiprazole fig3

figure - aripiprazole fig3

figure - aripiprazole fig4

figure - aripiprazole fig4

figure - aripiprazole fig5

figure - aripiprazole fig5

Figure 6: Kaplan-Meier Estimation of Cumulative Proportion of patients with Relapse (Schizophrenia Study 5) - aripiprazole fig6

Figure 6: Kaplan-Meier Estimation of Cumulative Proportion of patients with Relapse (Schizophrenia Study 5) - aripiprazole fig6

This is a graph of the Kaplan-Meier estimation showing the cumulative proportion of patients with relapse in schizophrenia study 5. The graph compares the proportion of patients who relapsed while taking Aripiprazole versus patients who were administered placebo. The X-axis denotes the number of days from randomization while the Y-axis shows proportion with relapse. The number of subjects at risk is also shown for both groups.*

Figure 9: Least Square Means of Change from Baseline in YGTSS TTS by Week (Tourette’s Disorder Study 1) - aripiprazole fig7

Figure 9: Least Square Means of Change from Baseline in YGTSS TTS by Week (Tourette’s Disorder Study 1) - aripiprazole fig7

The text describes a graph or chart that shows the change in YGTSS (Yale Global Tic Severity Scale) Total TIC Score over time, specifically from baseline to weeks of treatment, for a medication called aripiprazole. The graph compares low and high doses of the drug with a placebo. The data is presented as the least-squares mean change in the score.*

Aripiprazole Structure - aripiprazole str

Aripiprazole Structure - aripiprazole str

Label Image - lbl500906403

Label Image - lbl500906403

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.